Risk of thyroid neoplasms in patients with 22q11.2 deletion and DiGeorge-like syndromes: an insight for follow-up.

MLA

Sarli, Walter Maria, et al. “Risk of Thyroid Neoplasms in Patients with 22q11.2 Deletion and DiGeorge-like Syndromes: An Insight for Follow-Up.” Frontiers in Endocrinology, Aug. 2023, pp. 01–09. EBSCOhost, https://doi.org/10.3389/fendo.2023.1209577.

APA

Sarli, W. M., Ricci, S., Lodi, L., Cavone, F., Pacillo, L., Giancotta, C., Ubertini, G., Baroncelli, G., Cancrini, C., Azzari, C., & Stagi, S. (2023). Risk of thyroid neoplasms in patients with 22q11.2 deletion and DiGeorge-like syndromes: an insight for follow-up. Frontiers in Endocrinology, 01–09. https://doi.org/10.3389/fendo.2023.1209577

Chicago

Sarli, Walter Maria, Silvia Ricci, Lorenzo Lodi, Federica Cavone, Lucia Pacillo, Carmela Giancotta, Graziamaria Ubertini, et al. 2023. “Risk of Thyroid Neoplasms in Patients with 22q11.2 Deletion and DiGeorge-like Syndromes: An Insight for Follow-Up.” Frontiers in Endocrinology, August, 01–09. doi:10.3389/fendo.2023.1209577.